Organoid cultures for cancer modeling

Cell Stem Cell. 2023 Jul 6;30(7):917-937. doi: 10.1016/j.stem.2023.05.012. Epub 2023 Jun 13.

Abstract

Organoids derived from adult stem cells (ASCs) and pluripotent stem cells (PSCs) are important preclinical models for studying cancer and developing therapies. Here, we review primary tissue-derived and PSC-derived cancer organoid models and detail how they have the potential to inform personalized medical approaches in different organ contexts and contribute to the understanding of early carcinogenic steps, cancer genomes, and biology. We also compare the differences between ASC- and PSC-based cancer organoid systems, discuss their limitations, and highlight recent improvements to organoid culture approaches that have helped to make them an even better representation of human tumors.

Keywords: cancer; organoids.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Neoplasms* / pathology
  • Organoids
  • Pluripotent Stem Cells*